151 related articles for article (PubMed ID: 16362714)
1. Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study.
Gawel M; Aschoff J; May A; Charlesworth BR;
J Headache Pain; 2005 Oct; 6(5):405-11. PubMed ID: 16362714
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.
Diener HC; Evers S
Clin Drug Investig; 2007; 27(1):59-66. PubMed ID: 17177580
[TBL] [Abstract][Full Text] [Related]
4. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
Gawel M; Aschoff J; May A; Charlesworth BR;
Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
[TBL] [Abstract][Full Text] [Related]
5. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
Winner P; Farkas V; Štillová H; Woodruff B; Liss C; Lillieborg S; Raines S;
Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
[TBL] [Abstract][Full Text] [Related]
7. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
8. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
[TBL] [Abstract][Full Text] [Related]
9. Zolmitriptan nasal spray: advances in migraine treatment.
Syrett N; Abu-Shakra S; Yates R
Neurology; 2003 Oct; 61(8 Suppl 4):S27-30. PubMed ID: 14581655
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
11. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of zolmitriptan nasal spray in adolescent migraine.
Lewis DW; Winner P; Hershey AD; Wasiewski WW;
Pediatrics; 2007 Aug; 120(2):390-6. PubMed ID: 17671066
[TBL] [Abstract][Full Text] [Related]
13. Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older.
McKeage K
Paediatr Drugs; 2016 Feb; 18(1):75-81. PubMed ID: 26747634
[TBL] [Abstract][Full Text] [Related]
14. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.
Dowson AJ; MacGregor EA; Purdy RA; Becker WJ; Green J; Levy SL
Cephalalgia; 2002 Mar; 22(2):101-6. PubMed ID: 11972576
[TBL] [Abstract][Full Text] [Related]
15. Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers.
Yates R; Nairn K; Dixon R; Seaber E
J Clin Pharmacol; 2002 Nov; 42(11):1237-43. PubMed ID: 12412822
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers.
Yates R; Nairn K; Dixon R; Kemp JV; Dane AL
J Clin Pharmacol; 2002 Nov; 42(11):1244-50. PubMed ID: 12412823
[TBL] [Abstract][Full Text] [Related]
17. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
Hedlund C; Rapoport AM; Dodick DW; Goadsby PJ
Headache; 2009 Oct; 49(9):1315-23. PubMed ID: 19788472
[TBL] [Abstract][Full Text] [Related]
18. Myalgia and cramps associated with zolmitriptan.
Alonso-Navarro H; Jiménez-Jiménez FJ
Clin Neuropharmacol; 2005; 28(5):241-2. PubMed ID: 16239765
[TBL] [Abstract][Full Text] [Related]
19. Intranasal zolmitriptan for the treatment of acute migraine.
Tepper SJ; Chen S; Reidenbach F; Rapoport AM
Headache; 2013 Sep; 53 Suppl 2():62-71. PubMed ID: 24024604
[TBL] [Abstract][Full Text] [Related]
20. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
Geraud G; Compagnon A; Rossi A;
Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
